254 related articles for article (PubMed ID: 25098025)
1. Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction.
Pierson RA; Olatunbosun OA; Chizen DR; Saunders H; Loumaye E; De Moustier B
J Reprod Med; 2014; 59(7-8):355-66. PubMed ID: 25098025
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols.
Carone D; Caropreso C; Vitti A; Chiappetta R
J Endocrinol Invest; 2012 Dec; 35(11):996-1002. PubMed ID: 23095369
[TBL] [Abstract][Full Text] [Related]
3. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
4. Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction.
Serour GI; Aboulghar M; Al Bahar A; Hugues JN; Esmat K
Reprod Biol Endocrinol; 2014 Jun; 12():52. PubMed ID: 24942155
[TBL] [Abstract][Full Text] [Related]
5. Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility.
Howles CM; Alam V; Tredway D; Homburg R; Warne DW
Reprod Biomed Online; 2010 Feb; 20(2):182-90. PubMed ID: 20113956
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
Burgués S;
Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
[TBL] [Abstract][Full Text] [Related]
7. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
[TBL] [Abstract][Full Text] [Related]
8. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
[TBL] [Abstract][Full Text] [Related]
9. Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study.
Hugues JN; Soussis J; Calderon I; Balasch J; Anderson RA; Romeu A;
Hum Reprod; 2005 Mar; 20(3):629-35. PubMed ID: 15618252
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization.
Thuesen LL; Loft A; Egeberg AN; Smitz J; Petersen JH; Andersen AN
Hum Reprod; 2012 Oct; 27(10):3074-84. PubMed ID: 22791754
[TBL] [Abstract][Full Text] [Related]
11. Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low-dose step-up protocol with weekly increments of 25 international units of follicle-stimulating hormone.
Leader A;
Fertil Steril; 2006 Jun; 85(6):1766-73. PubMed ID: 16759926
[TBL] [Abstract][Full Text] [Related]
12. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG.
International Recombinant Human Chorionic Gonadotropin Study Group
Fertil Steril; 2001 Jun; 75(6):1111-8. PubMed ID: 11384635
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
Frydman R; Howles CM; Truong F
Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
[TBL] [Abstract][Full Text] [Related]
14. [Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer].
Xu SR; Li Y; Liu H; Li HY; Tang R; Gao Q; Sheng Y; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):420-3. PubMed ID: 21029591
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.
Lehert P; Kolibianakis EM; Venetis CA; Schertz J; Saunders H; Arriagada P; Copt S; Tarlatzis B
Reprod Biol Endocrinol; 2014 Feb; 12():17. PubMed ID: 24555766
[TBL] [Abstract][Full Text] [Related]
16. Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation.
Lee KL; Couchman GM; Walmer DK
J Assist Reprod Genet; 2005 Jan; 22(1):37-40. PubMed ID: 15807221
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
European Recombinant LH Study Group
J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
[TBL] [Abstract][Full Text] [Related]
18. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
[TBL] [Abstract][Full Text] [Related]
19. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
van Santbrink EJ; Fauser BC
J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
[TBL] [Abstract][Full Text] [Related]
20. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]